Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 1:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2689–2712 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Male Sexual Dysfunction, Ejaculatory Dysfunction
Interventions: BTL Emsella Chair; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older · Male only
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: COVID-19
Interventions: Subjects with and without Long COVID; Biological
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Schizophrenia, Dementia
Interventions: Huperzine A; Drug
Lead sponsor: VA Nebraska Western Iowa Health Care System; Federal
Eligibility: 19 Years to 59 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Mild Cognitive Impairment
Interventions: Usual Care, WATER+CT; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 90 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prodromal Alzheimer's Disease, Mild Cognitive Impairment, Subjective Cognitive Complaints
Interventions: Digital Memory Notebook (DMN) Application; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Disease/Condition Name Cancer-related Cognitive Dysfunction, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia, BCR-ABL1 Positive
Interventions: Not listed
Lead sponsor: University of Rochester NCORP Research Base; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Cancer, Cardiovascular Disease, Neurologic Dysfunction, Congenital Abnormalities, Hearing Loss
Interventions: Experimental; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 645 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Psychosocial Well-being, Neurocognitive Function, Cognitive Complaint, Cognitive Dysfunction
Interventions: taVNS, Computerized Cognitive Training; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 45 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Sinusoidal Obstruction Syndrome
Interventions: Serial Blood Draws; Other
Lead sponsor: Indiana University; Other
Eligibility: Up to 25 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Indianapolis, Indiana • Ann Arbor, Michigan + 1 more

Conditions: Dyspareunia, Perineal Tear, Sutured Laceration
Interventions: Laceration Repair with Polyglactin 910, Laceration Repair with poliglecaprone 25; Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Anemia, Sickle Cell
Interventions: NP Battery, MRI; Behavioral · Procedure
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 21 Years to 55 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 12
States / cities: Los Angeles, California • Oakland, California • Hollywood, Florida + 8 more

Conditions: Cognitive Impairment, Subjective Cognitive Decline, Mild Cognitive Impairment (MCI)
Interventions: Brain Health Together; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 8
States / cities: Birmingham, Alabama • La Jolla, California • San Diego, California + 4 more

Conditions: Chronic Granulomatous Disease (CGD)
Interventions: Not listed
Lead sponsor: Ensoma; Industry
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 50
States / cities: Montgomery, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 47 more

Conditions: Menopause, Sexual Dysfunction, Libido Disorder, Testosterone Deficiency
Interventions: Transdermal testosterone gel, Transdermal placebo gel; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Schizotypal Personality Disorder, SPD
Interventions: DAR 0-100A, Placebo; Drug
Lead sponsor: Antonia New; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Memantine, Placebo, Whole brain radiation therapy; Drug · Other · Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years to 120 Years
Enrollment: 554 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 229
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 183 more

Conditions: Blood Sugar (Glucose) Control, Blood Vessel (Vascular) Dysfunction
Interventions: Whey protein powder, Control protein; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Effect of Bike Seats on Male Perineal Blood Flow
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prediabetic State, Insulin Resistance, Middle Age, Prehypertension, Mild Cognitive Impairment
Interventions: Low Diet, High Diet; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 45 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Prostate Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
Interventions: radiation therapy; Radiation
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypopituitarism, Hypogonadism, Thyroid Dysfunction, Bone Diseases, Metabolic
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 2 Years to 24 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Fatigue Syndrome
Interventions: Nutraceutical supplements, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 25 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Depression
Interventions: riluzole; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Emsella Chair vs Sham for Male Sexual Dysfunction

Dysbiosis & Long COVID

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

Water-based Activity to Enhance Recall in Veterans: A Randomized Clinical Trial

The Digital Memory Notebook

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing

taVNS + CCT for Neurocognitive Rehab

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair

Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease

Brain Health Together: Development and Pilot Test

Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause

A D1 Agonist For Working Memory

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Whey Protein Effects on Gycemic Control and Vascular Function

Study of Bicycle Seat Effects on Male Perineal Blood Flow

Macronutrient Effects on Alzheimer's Disease (MEAL-2)

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder

Riluzole to Treat Major Depression